NHS hub launches MedTech NAVIGATOR with £1mn grant

By William Girling
Health Enterprise East (HEE), one of the NHS’ principle innovation hubs, has recently been awarded £1mn to develop its NAVIGATOR programme. Provided...

Health Enterprise East (HEE), one of the NHS’ principle innovation hubs, has recently been awarded £1mn to develop its NAVIGATOR programme.

Provided by the European Regional Development Fund (ERDF), the grant will allow HEE to deliver a series of events, initiatives and reports via the MedTech NAVIGATOR over a three-year timespan. 

The digital solution was conceived as a method of driving innovation and fostering collaboration between healthcare providers, academics and trailblazing SMEs. 

Able to identify unmet needs, generate market insights, link databases, support the development of SMEs and improve analytical capabilities, MedTech NAVIGATOR could prove highly significant for the East of England’s medical capacity. 

Forming partnerships to create solutions

Regarding the launch, Joop Tanis, Director of MedTech Consulting at HEE, said, “In our experience, effective partnerships lie at the heart of successful medtech innovation. 

“All too often, clinicians and developers with good ideas fail to connect and as a result potentially great innovations don’t make it off the drawing board. 

SEE ALSO:

“The MedTech NAVIGATOR is designed to make collaboration between NHS and industry innovators as seamless as possible, facilitating introductions and knowledge sharing at the very earliest stages of product development.”

Tanis confirmed that initial uptake for the idea had been enthusiastic and demonstrated a strong appetite for the continuation of the project. 

“We are thrilled to be working with the European Regional Development Fund to deliver this programme and are excited to find out what lies ahead,” he added.

Tackling relevant medical topics

Significantly, considering current concerns over the Covid-19 (coronavirus) outbreak (which is now officially a pandemic, according to the WHO), the programme’s first research theme will be respiratory disease.

It’s possible that the effects of coronavirus, the symptoms of which include shortness of breath and which can adversely affect pre-existing medical conditions such as asthma, could also be explored by this research.

For more information on healthcare topics - please take a look at the latest edition of Healthcare Global.

Follow us on LinkedIn and Twitter.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare